Mithrl
PrivateLast Round
Series A
Sep 15, 2026
Total Funding Raised
$24M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Mithrl operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in September 2026.
Mithrl is a life sciences software company that provides an AI-powered platform to automate and accelerate the analysis of complex biological data for scientific research labs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, NLP & Conversational AI, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mithrl Comparables
Compare Mithrl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Edison Scientific | 76% | |
| Seqera | 63% | |
| LatchBio | 62% |
For institutional investors. Book with your work email.
Mithrl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 15, 2026 | ||||
| Seed | Nov 14, 2024 | ||||
| Seed | Sep 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mithrl Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Obvious Ventures | Series A |
| Sequoia Capital | Seed |
| AGI House | Series A |
| Bonfire Ventures | Seed |
| Headline | Series A |
| AGI House Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
$20M round led by Obvious Ventures.
- Aug 1, 2026
Grew 24% QoQ, from 21 to 26 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 17, 2026
Mithrl is launching an early access program for Mithrl-1, its second-generation AI platform that helps biopharmaceutical teams accelerate R&D, on Sep 21st '26.
- receives_financingSep 16, 2026
Mithrl receives $20M in Series A funding led by Obvious Ventures, with Headline, AGI House, and several pharmaceutical executives participating, to develop the second generation of its biomedical world model and expand platform deployments across therapeutic areas in United States.
For institutional investors. Book with your work email.
Mithrl Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mithrl's valuation, stock price, and market status.
Is Mithrl a public or private company?
Mithrl is a private company.
What is the current stock price of Mithrl?
Mithrl is a private company, so its shares have no public market price. Caplight tracks Mithrl's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mithrl worth (valuation)?
Valuation information for Mithrl is not publicly available.
Can I buy Mithrl stock?
Mithrl shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mithrl's last funding round?
Mithrl's most recent funding round was Series A on September 15, 2026.
Who are the main investors in Mithrl?
Key investors in Mithrl include Obvious Ventures, Sequoia Capital, Bonfire Ventures.
Will Mithrl IPO soon?
No public IPO plans have been announced for Mithrl.
How can I track Mithrl secondary market activity?
Caplight tracks bids, offers, and trades in Mithrl's shares on secondary markets.